{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T15:48:16Z","timestamp":1764604096863,"version":"build-2065373602"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015371","name":"ReCor Medical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015371","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","interventional.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Interventional Cardiology Clinics"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.iccl.2024.11.008","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T04:10:29Z","timestamp":1737691829000},"page":"225-234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Renal Denervation"],"prefix":"10.1016","volume":"14","author":[{"given":"Monica","family":"Tung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taisei","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh V.","family":"Swaminathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debbie L.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dmitriy N.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Fulton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.iccl.2024.11.008_bib1","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000001123","article-title":"Heart disease and stroke statistics\u20142023 update: a report from the American Heart Association","volume":"147","author":"Tsao","year":"2023","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.iccl.2024.11.008_bib2","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1161\/HYPERTENSIONAHA.119.13616","article-title":"National rates of nonadherence to antihypertensive medications among insured adults with hypertension, 2015","volume":"74","author":"Chang","year":"2019","journal-title":"Hypertension"},{"year":"2015","series-title":"Renal denervation: a new approach to treatment of resistant hypertension","key":"10.1016\/j.iccl.2024.11.008_bib3"},{"issue":"23","key":"10.1016\/j.iccl.2024.11.008_bib4","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1016\/j.jacc.2019.04.015","article-title":"Renal denervation update from the international sympathetic nervous system summit","volume":"73","author":"Kiuchi","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.iccl.2024.11.008_bib5","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMc0904179","article-title":"Renal sympathetic-nerve ablation for uncontrolled hypertension","volume":"361","author":"Schlaich","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"10.1016\/j.iccl.2024.11.008_bib6","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1016\/j.jacc.2021.04.044","article-title":"Changes in plasma renin activity after renal artery sympathetic denervation","volume":"77","author":"Mahfoud","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10234","key":"10.1016\/j.iccl.2024.11.008_bib7","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/S0140-6736(20)30554-7","article-title":"Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial","volume":"395","author":"B\u00f6hm","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.iccl.2024.11.008_bib8","doi-asserted-by":"crossref","DOI":"10.17925\/HI.2024.18.1.2","article-title":"Renal denervation for hypertension: the current landscape and future directions","volume":"18","author":"Fulton","year":"2024","journal-title":"Heart Int"},{"issue":"11","key":"10.1016\/j.iccl.2024.11.008_bib9","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.4244\/EIJY14M10_14","article-title":"Controlled circumferential renal sympathetic denervation with preservation of the renal arterial wall using intraluminal ultrasound: a next-generation approach for treating sympathetic overactivity","volume":"10","author":"Sakakura","year":"2015","journal-title":"EuroIntervention"},{"issue":"24","key":"10.1016\/j.iccl.2024.11.008_bib10","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1161\/CIRCULATIONAHA.124.069291","article-title":"Effect of alcohol-mediated renal denervation on blood pressure in the presence of antihypertensive medications: primary results from the TARGET BP I randomized clinical trial","volume":"149","author":"Kandzari","year":"2024","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.iccl.2024.11.008_bib11","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.carrev.2015.04.008","article-title":"Next generation renal denervation: chemical \u201cperivascular\u201d renal denervation with alcohol using a novel drug infusion catheter","volume":"16","author":"Fischell","year":"2015","journal-title":"Cardiovasc Revascularization Med"},{"issue":"6","key":"10.1016\/j.iccl.2024.11.008_bib12","article-title":"SCAI position statement on renal denervation for hypertension: patient selection, operator competence, training and techniques, and organizational recommendations","volume":"2","author":"Swaminathan","year":"2023","journal-title":"J\u00a0Soc Cardiovasc Angiogr Interv"},{"issue":"10137","key":"10.1016\/j.iccl.2024.11.008_bib13","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/S0140-6736(18)31082-1","article-title":"Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial","volume":"391","author":"Azizi","year":"2018","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.iccl.2024.11.008_bib14","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1001\/jama.2023.0713","article-title":"Endovascular ultrasound renal denervation to treat hypertension: the RADIANCE II Randomized Clinical Trial","volume":"329","author":"Azizi","year":"2023","journal-title":"JAMA"},{"issue":"10137","key":"10.1016\/j.iccl.2024.11.008_bib15","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1016\/S0140-6736(18)30951-6","article-title":"Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial","volume":"391","author":"Kandzari","year":"2018","journal-title":"Lancet"},{"issue":"10333","key":"10.1016\/j.iccl.2024.11.008_bib16","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/S0140-6736(22)00455-X","article-title":"Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial","volume":"399","author":"Mahfoud","year":"2022","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.iccl.2024.11.008_bib17","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/j.jacc.2023.08.045","article-title":"Safety and efficacy of renal denervation in patients taking antihypertensive medications","volume":"82","author":"Kandzari","year":"2023","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.iccl.2024.11.008_bib18","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1161\/HYPERTENSIONAHA.123.22251","article-title":"Impact of antihypertensive medication changes after renal denervation among different patient groups: SPYRAL HTN-on MED","volume":"81","author":"Townsend","year":"2024","journal-title":"Hypertension"},{"issue":"10293","key":"10.1016\/j.iccl.2024.11.008_bib19","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/S0140-6736(21)00788-1","article-title":"Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial","volume":"397","author":"Azizi","year":"2021","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.iccl.2024.11.008_bib20","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1161\/CIRCULATIONAHA.118.037654","article-title":"A\u00a0three-arm randomized trial of different renal denervation devices and techniques in patients with resistant hypertension (RADIOSOUND-HTN)","volume":"139","author":"Fengler","year":"2019","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.iccl.2024.11.008_bib21","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jcin.2022.10.058","article-title":"6- and 12-month follow-up from a randomized clinical trial of ultrasound vs radiofrequency renal denervation (RADIOSOUND-HTN)","volume":"16","author":"Fengler","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"issue":"42","key":"10.1016\/j.iccl.2024.11.008_bib22","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1093\/eurheartj\/ehz118","article-title":"Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the Global SYMPLICITY Registry","volume":"40","author":"Mahfoud","year":"2019","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.iccl.2024.11.008_bib23","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1161\/HYPERTENSIONAHA.123.21283","article-title":"Outcomes following radiofrequency renal denervation according to antihypertensive medications: subgroup analysis of the global SYMPLICITY registry DEFINE","volume":"80","author":"Mahfoud","year":"2023","journal-title":"Hypertension"},{"issue":"10361","key":"10.1016\/j.iccl.2024.11.008_bib24","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(22)01787-1","article-title":"Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial","volume":"400","author":"Bhatt","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.iccl.2024.11.008_bib25","doi-asserted-by":"crossref","DOI":"10.1007\/s00392-023-02325-x","article-title":"Real-world experience with ultrasound renal denervation utilizing home blood pressure monitoring: the Global Paradise System registry study design","author":"Mahfoud","year":"2023","journal-title":"Clin Res Cardiol"},{"issue":"3","key":"10.1016\/j.iccl.2024.11.008_bib26","first-page":"416","article-title":"Renal denervation in hypertension patients: proceedings from an expert consensus roundtable cosponsored by SCAI and NKF","volume":"98","author":"Kandzari","year":"2021","journal-title":"Cathet Cardio Intervent"},{"issue":"15","key":"10.1016\/j.iccl.2024.11.008_bib27","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/eurheartj\/ehad054","article-title":"Renal denervation in the management of hypertension in adults. A clinical consensus statement of the\u00a0ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)","volume":"44","author":"Barbato","year":"2023","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.iccl.2024.11.008_bib28","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s41669-024-00472-z","article-title":"Cost effectiveness of endovascular ultrasound renal denervation in patients with resistant hypertension","volume":"8","author":"Taylor","year":"2024","journal-title":"PharmacoEconomics Open"},{"key":"10.1016\/j.iccl.2024.11.008_bib29","first-page":"qcae001","article-title":"Cost-effectiveness of catheter-based radiofrequency renal denervation for the treatment of uncontrolled hypertension: an analysis for the UK based on recent clinical evidence","author":"Sharp","year":"2024","journal-title":"Eur Heart J - Qual Care Clin Outcomes"},{"issue":"9","key":"10.1016\/j.iccl.2024.11.008_bib30","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1056\/NEJMp1405158","article-title":"Updating cost-effectiveness \u2014 the curious resilience of the $50,000-per-QALY Threshold","volume":"371","author":"Neumann","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iccl.2024.11.008_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jscai.2024.102234","article-title":"Catheter-based radiofrequency renal denervation in the United States: a cost-effectiveness analysis based on contemporary evidence","author":"Kandzari","year":"2024","journal-title":"Journal of the Society for Cardiovascular Angiography & Interventions"},{"issue":"10","key":"10.1016\/j.iccl.2024.11.008_bib32","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1089\/wound.2013.0483","article-title":"CPT \u00ae codes: what are they, why are they necessary, and how are they developed?","volume":"2","author":"Dotson","year":"2013","journal-title":"Adv Wound Care"},{"key":"10.1016\/j.iccl.2024.11.008_bib33","article-title":"Long-term changes in atrial arrhythmia burden after renal denervation combined with pulmonary vein isolation","author":"Chinitz","year":"2024","journal-title":"JACC (J Am Coll Cardiol)"},{"issue":"3","key":"10.1016\/j.iccl.2024.11.008_bib34","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1001\/jama.2019.21187","article-title":"Effect of renal denervation and catheter ablation vs catheter ablation alone on atrial fibrillation recurrence among patients with paroxysmal atrial fibrillation and hypertension: the ERADICATE-AF randomized clinical trial","volume":"323","author":"Steinberg","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.iccl.2024.11.008_bib35","first-page":"109","article-title":"Renal sympathetic denervation as upstream therapy during atrial fibrillation ablation","volume":"7","author":"Turagam","year":"2021","journal-title":"JACC (J Am Coll Cardiol)"},{"issue":"33","key":"10.1016\/j.iccl.2024.11.008_bib36","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1093\/eurheartj\/ehu093","article-title":"Effect of renal denervation on left ventricular mass and function in patients with resistant hypertension: data from a multi-centre cardiovascular magnetic resonance imaging trial","volume":"35","author":"Mahfoud","year":"2014","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.iccl.2024.11.008_bib37","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1038\/s41440-023-01287-x","article-title":"Multi-organ denervation: a novel approach to combat cardiometabolic disease","volume":"46","author":"Kiuchi","year":"2023","journal-title":"Hypertens Res"}],"container-title":["Interventional Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211745824001263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211745824001263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T12:24:03Z","timestamp":1762604643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211745824001263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S2211745824001263"],"URL":"https:\/\/doi.org\/10.1016\/j.iccl.2024.11.008","relation":{},"ISSN":["2211-7458"],"issn-type":[{"type":"print","value":"2211-7458"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renal Denervation","name":"articletitle","label":"Article Title"},{"value":"Interventional Cardiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iccl.2024.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}